Morris Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $794K | Hold |
1,747
| – | – | 0.75% | 32 |
|
2022
Q2 | $843K | Sell |
1,747
-46
| -3% | -$22.2K | 0.75% | 31 |
|
2022
Q1 | $881K | Sell |
1,793
-15
| -0.8% | -$7.37K | 0.68% | 33 |
|
2021
Q4 | $838K | Sell |
1,808
-147
| -8% | -$68.1K | 0.62% | 33 |
|
2021
Q3 | $729K | Sell |
1,955
-146
| -7% | -$54.4K | 0.57% | 37 |
|
2021
Q2 | $802K | Hold |
2,101
| – | – | 0.61% | 37 |
|
2021
Q1 | $754K | Sell |
2,101
-188
| -8% | -$67.5K | 0.61% | 37 |
|
2020
Q4 | $735K | Sell |
2,289
-57
| -2% | -$18.3K | 0.6% | 40 |
|
2020
Q3 | $630K | Sell |
2,346
-68
| -3% | -$18.3K | 0.56% | 38 |
|
2020
Q2 | $635K | Buy |
2,414
+20
| +0.8% | +$5.26K | 0.57% | 38 |
|
2020
Q1 | $544K | Sell |
2,394
-56
| -2% | -$12.7K | 0.58% | 34 |
|
2019
Q4 | $740K | Sell |
2,450
-87
| -3% | -$26.3K | 0.62% | 34 |
|
2019
Q3 | $609K | Hold |
2,537
| – | – | 0.54% | 38 |
|
2019
Q2 | $716K | Hold |
2,537
| – | – | 0.6% | 32 |
|
2019
Q1 | $728K | Sell |
2,537
-10
| -0.4% | -$2.87K | 0.57% | 30 |
|
2018
Q4 | $669K | Sell |
2,547
-90
| -3% | -$23.6K | 0.57% | 31 |
|
2018
Q3 | $723K | Sell |
2,637
-56
| -2% | -$15.4K | 0.48% | 32 |
|
2018
Q2 | $641K | Sell |
2,693
-6
| -0.2% | -$1.43K | 0.45% | 35 |
|
2018
Q1 | $593K | Buy |
2,699
+30
| +1% | +$6.59K | 0.39% | 42 |
|
2017
Q4 | $601K | Sell |
2,669
-5
| -0.2% | -$1.13K | 0.39% | 42 |
|
2017
Q3 | $508K | Buy |
2,674
+12
| +0.5% | +$2.28K | 0.34% | 48 |
|
2017
Q2 | $501K | Sell |
2,662
-9
| -0.3% | -$1.69K | 0.35% | 50 |
|
2017
Q1 | $442K | Sell |
2,671
-144
| -5% | -$23.8K | 0.32% | 52 |
|
2016
Q4 | $405K | Sell |
2,815
-5
| -0.2% | -$719 | 0.28% | 53 |
|
2016
Q3 | $353K | Sell |
2,820
-4
| -0.1% | -$501 | 0.22% | 57 |
|
2016
Q2 | $371K | Sell |
2,824
-66
| -2% | -$8.67K | 0.22% | 54 |
|
2016
Q1 | $402K | Buy |
2,890
+296
| +11% | +$41.2K | 0.27% | 52 |
|
2015
Q4 | $362K | Buy |
+2,594
| New | +$362K | 0.25% | 54 |
|